Full text of the official published hearing record. Extracted from the source document — verify against the official record for citation.
[House Hearing, 119 Congress] [From the U.S. Government Publishing Office] OVERSIGHT OF THE U.S. PATENT AND TRADEMARK OFFICE ======================================================================= HEARING BEFORE THE SUBCOMMITTEE ON COURTS, INTELLECTUAL PROPERTY, ARTIFICIAL INTELLIGENCE, AND THE INTERNET OF THE COMMITTEE ON THE JUDICIARY U.S. HOUSE OF REPRESENTATIVES ONE HUNDRED NINETEENTH CONGRESS SECOND SESSION __________ WEDNESDAY, MARCH 25, 2026 __________ Serial No. 119-62 __________ Printed for the use of the Committee on the Judiciary [GRAPHIC NOT AVAILABLE IN TIFF FORMAT] Available via: http://judiciary.house.gov __________ U.S. GOVERNMENT PUBLISHSING OFFICE 63-299 WASHINGTON : 2026 ======================================================================= COMMITTEE ON THE JUDICIARY JIM JORDAN, Ohio, Chair DARRELL ISSA, California JAMIE RASKIN, Maryland, Ranking ANDY BIGGS, Arizona Member TOM McCLINTOCK, California JERROLD NADLER, New York THOMAS P. TIFFANY, Wisconsin ZOE LOFGREN, California THOMAS MASSIE, Kentucky STEVE COHEN, Tennessee CHIP ROY, Texas HENRY C. ``HANK'' JOHNSON, Jr., SCOTT FITZGERALD, Wisconsin Georgia BEN CLINE, Virginia ERIC SWALWELL, California LANCE GOODEN, Texas TED LIEU, California JEFFERSON VAN DREW, New Jersey PRAMILA JAYAPAL, Washington TROY E. NEHLS, Texas J. LUIS CORREA, California BARRY MOORE, Alabama MARY GAY SCANLON, Pennsylvania HARRIET M. HAGEMAN, Wyoming JOE NEGUSE, Colorado LAUREL M. LEE, Florida LUCY McBATH, Georgia WESLEY HUNT, Texas DEBORAH K. ROSS, North Carolina RUSSELL FRY, South Carolina BECCA BALINT, Vermont GLENN GROTHMAN, Wisconsin JESUS G. ``CHUY'' GARCIA, Illinois BRAD KNOTT, North Carolina SYDNEY KAMLAGER-DOVE, California MARK HARRIS, North Carolina JARED MOSKOWITZ, Florida ROBERT F. ONDER, Jr., Missouri DANIEL S. GOLDMAN, New York DEREK SCHMIDT, Kansas JASMINE CROCKETT, Texas BRANDON GILL, Texas MICHAEL BAUMGARTNER, Washington Vacancy ------ SUBCOMMITTEE ON COURTS, INTELLECTUAL PROPERTY, ARTIFICIAL INTELLIGENCE, AND THE INTERNET DARRELL ISSA, California, Chair THOMAS MASSIE, Kentucky HENRY C. ``HANK'' JOHNSON, Jr., SCOTT FITZGERALD, Wisconsin Georgia, Ranking Member BEN CLINE, Virginia ZOE LOFGREN, California LANCE GOODEN, Texas TED LIEU, California LAUREL LEE, Florida JOE NEGUSE, Colorado RUSSELL FRY, South Carolina DEBORAH ROSS, North Carolina MICHAEL BAUMGARTNER, Washington ERIC SWALWELL, California Vacancy SYDNEY KAMLAGER-DOVE, California CHRISTOPHER HIXON, Majority Staff Director ARTHUR EWENCZYK, Minority Staff Director C O N T E N T S ---------- Wednesday, March 25, 2026 OPENING STATEMENTS Page The Honorable Darrell Issa, Chair of the Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet from the State of California.......................... 1 The Honorable Henry C. ``Hank'' Johnson, Ranking Member of the Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet from the State of Georgia....... 7 The Honorable Jim Jordan, Chair of the Committee on the Judiciary from the State of Ohio......................................... 8 The Honorable Jamie Raskin, Ranking Member of the Committee on the Judiciary from the State of Maryland....................... 8 WITNESS The Hon. John A. Squires, Under Secretary of Commerce, Intellectual Property and Director, U.S. Patent and Trademark Office Oral Testimony................................................. 12 Prepared Testimony............................................. 14 LETTERS, STATEMENTS, ETC. SUBMITTED FOR THE HEARING All materials submitted for the record by the Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet are listed below...................................... 57 Materials submitted by the Honorable Zoe Lofgren, a Member of the Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet from the State of California, for the record A letter to the Honorable John Squires, Under Secretary of Commerce, Intellectual Property and Director, U.S. Patent and Trademark Office entitled, ``Additional Discretionary Institution Considerations,'' from Alliance for Automotive Innovation, Business Software Alliance, High Tech Inventors Alliance, Software & Information Industry Association, United for Patent Reform, and US Manufacturers Association for Development & Enterprise (US*MADE), Mar. 24, 2026 A report entitled, ``Analysis of Unpatentability Findings in Inter Partes Review Final Written Decisions (2013- 2025),'' Gaetan de Rassenfosse (EPFL) & Laura Sheridan (Google), Mar. 15, 2026 A letter to the Honorables Howard Lutnick, John Squires, Scott Bessent, Susie Wiles, Kevin Hassett, Russell Vought, and Peter Navarro, from Randy Landreneau, President, and Dirk Tomsin, COO, US Inventor, Inc., submitted by the Honorable Thomas Massie, a Member of the Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet from the State of Kentucky, for the record Materials submitted by the Honorable Kamlager-Dove, a Member of the Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet from the State of California, for the record An article entitled, ``Trump Appointees Are Hijacking the Patent System,'' May 15, 2025, The American Prospect An article entitled, ``Trump PTO Pick's Fortress Ties Signal Big Tech Patent Fights,'' Mar. 11, 2025, Bloomberg Government Materials submitted by the Honorable Darrell Issa, Chair of the Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet from the State of California, for the record A letter to the Hon. John A. Squires, Under Secretary of Commerce, Intellectual Property and Director, U.S. Patent and Trademark Office, from the Alliance for Automotive Innovation, Business Software Alliance, High Tech Inventors Alliance, Software & Information Industry Association, United for Patent Reform, and US Manufacturers Association for Development & Enterprise (US*MADE), Mar. 24, 2026 A comment entitled, ``Comment by Anonymous,'' Dec 3, 2025, U.S. Patent and Trademark Office A comment entitled,``Comments of SIIA Regarding the Notice of Proposed Rulemaking:Revision to Rules of Practice Before the Patent Trial and Appeal Board,'' Dec. 2, 2025, Software and Information Industry Association (SIAA) A letter to the Hon. John A. Squires, Under Secretary of Commerce, Intellectual Property and Director, U.S. Patent and Trademark Office, from Arnold Ventures, Dec. 1, 2025 A letter to the Hon. John A. Squires, Under Secretary of Commerce, Intellectual Property and Director, U.S. Patent and Trademark Office, from BadVR, Inc., Nov. 13, 2025 A comment entitled, ``Comments on Notice of Proposed Rulemaking: Revision to Rules of Practice Before the Patent Trial and Appeal Board,'' from Business Software Alliance (BSA) (FR 2025-19580), Dec. 2025 A letter to the Hon. John A. Squires, Under Secretary of Commerce, Intellectual Property and Director, U.S. Patent and Trademark Office, from the Consumer Technology Association (CTA) (90 FR 48,335) A letter to the Hon. John A. Squires, Under Secretary of Commerce, Intellectual Property and Director, U.S. Patent and Trademark Office, from Crypto Council for Innovation (CCI), Dec. 2, 2025 A comment to the Hon. John A. Squires, Under Secretary of Commerce, Intellectual Property and Director, U.S. Patent and Trademark Office, from Entertainment Software Association (Docket PTO-P-2025-0025), Dec. 2, 2025 A comment entitled, ``Comment by e-td55 llc,'' to the Hon. John A. Squires, Under Secretary of Commerce, Intellectual Property and Director, U.S. Patent and Trademark Office (Docket PTO-P-2025-0025-1514), Nov. 26, 2025 A comment entitled, ``Revision to Rules of Practice Before the Patent Trial and Appeal Board,'' Generation Patient (Docket PTO-P-2025-0025) A letter to the Committee on the Judiciary, from Software & Information Industry Association (SIIA) A comment from the National Retail Federation (NRF), Dec, 2, 2025 A letter to the Hon. John A. Squires, Under Secretary of Commerce, Intellectual Property and Director, U.S. Patent and Trademark Office, from Patients For Affordable Drugs (P4AD), Nov. 21, 2025 A comment to the Hon. John A. Squires, Under Secretary of Commerce, Intellectual Property and Director, U.S. Patent and Trademark Office, from Senseeker Corp. (PTO-P-2025- 0025-0894), Dec. 3, 2025 A letter to the Hon. Chuck Grassley, Chair of the Committee on the Judiciary, the Hon. Jim Jordan, Chair of the Committee on the Judiciary, the Hon. Dick Durbin, Ranking Member of the Committee on the Judiciary, and the Hon. Jamie Rasking, Ranking Member of the Committee on the Judiciary, from the Hon. John A. Squires, Under Secretary of Commerce, Intellectual Property and Director, U.S. Patent and Trademark Office, Dec. 9, 2025 A comment from the U.S. Manufacturers Association for Development and Enterprise (PTO-P-2025-0025), Dec. 2, 2025 A letter to the Honorable Darrell Issa, Chair of the Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet from the State of California, and the Honorable Henry C. ``Hank'' Johnson, Ranking Member of the Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet from the State of Georgia, from Alliance for Automotive Innovation, Mar. 23, 2026 A letter to the Honorable Darrell Issa, Chair of the Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet from the State of California, and the Honorable Henry C. ``Hank'' Johnson, Ranking Member of the Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet from the State of Georgia, from the Council for Innovation Promotion, Mar. 24, 2026, submitted by the Honorable Henry C. ``Hank'' Johnson, Ranking Member of the Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet from the State of Georgia, for the record QUESTIONS AND RESPONSES FOR THE RECORD Questions for the Hon. John A. Squires, Under Secretary of Commerce, Intellectual Property and Director, U.S. Patent and Trademark Office, submitted by the Honorables Ben Cline from the State of Virginia; the Honorables Thomas Massie from State of Kentucky; the Honorable Zoe Lofgren from the State of California; the Honorable Joe Neguse from the State of Colorado; the Honorable Henry C. ``Hank'' Johnson from the State of Georgia; and the Honorable Kamlager-Dove, from the State of California; the Honorable Darrell Issa from the State of California, the Members of the Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet, for the record No response at the time of publication OVERSIGHT OF THE U.S. PATENT AND TRADEMARK OFFICE ---------- Wednesday, March 25, 2026 House of Representatives Subcommittee on Courts, Intellectual Property, and Artificial Intelligence, and the Internet Committee on the Judiciary Washington, DC The Committee met, pursuant to notice, at 10 a.m., in Room 2141, Rayburn House Office Building, the Hon. Darrell Issa [Chair of the Subcommittee] presiding. Members present: Representatives Issa, Jordan, Massie, Fitzgerald, Cline, Gooden, Kiley, Lee, Fry, Johnson, Raskin, Lofgren, Ross, and Kamlager-Dove. Mr. Issa. Good morning. The Subcommittee will come to order. Without objection, the Chair is authorized to declare a recess at anytime. We welcome everyone here to today's hearing on the United States Patent and Trademark Office, and I want to make it clear that at the stroke of 10 we started which is practically a record, but also that this is an extremely busy day. Most Members serve on two or three Committees, so you will see them coming in and out. Mr. Squires, that is not any reflection on you because there were equivalent people in at least two other hearing rooms for many of our people, but I suspect you will see in and out virtually every Member of the Subcommittee. Also, in addition, it is the policy of the Subcommittee, should any Members of the Full Committee come, they will be waived on either side without objection. I now recognize myself for an opening statement. Mr. Raskin. Mr. Chair, just to be clear, any Member who arrives from the Committee will be waived on. Mr. Issa. We waive on. The specifics of the Committee rules are that they still have to be yielded time from a Member of the Subcommittee. Mr. Raskin. Got you. Mr. Issa. I always say that so that everyone understands in advance. Also, that pursuant to the rules of the Full Committee, we won't waive on people who are not members of the Judiciary Committee. Mr. Raskin. Thank you, Mr. Chair. Mr. Issa. Thank you. We welcome the Ranking Member of the Full Committee here, too. Normally, I make relatively short opening statements, but this is a particularly important hearing. It is important because there has never been a time in our history in which getting it right, not just on patents as we have known them, but patents are as they are emerging. I want to thank the Under Secretary for, among other things, clarifying in AI the pathway to patentability. I certainly think that when we look at the ambitious agenda set out by President Trump, he selected well an Under Secretary to make sure that we can reach that. One of the first actions of Mr. Squires was, in fact, as Director, to take steps to move the President's AI agenda and to strongly support it. This meant going above and beyond and with some changes to the Biden era's policy which came out late in the administration. This thoughtful change, I believe, will bear well for the foreseeable future. Like everything else in AI, I will expect it will not be the last time that guidance will have to come either from the Director or, if necessary, from Congress. In fact, as we speak, we still live with the memory of the Copyright Office saying that AI is not copyrightable and the idea that AI-assisted production is not copyrightable or patentable, of course, is now in our tail lights, but it will not leave our memory. Additionally, under the Director's guidance, he set forth these clear guidelines for innovation. This, I believe, will accelerate the examination, but it comes with a price. As we know, AI is a wonderful tool, but AI can, in fact, extend and elongate patents, patents that might have had ten claims and a few dependent claims, now might have thousands of claims. That means that one of the things that the Director has asked for that we have to take serious consideration on is how we deal with long or particularly complex patents should there be a multitiered, and this will be discussed today, should there be a multitiered process for billing? As many on this Committee know, when the Congress on a bipartisan basis, bicameral basis, made it two decisions. One was that fee setting would be transferred substantially to the Trademark Office, Patent and Trademark Office, but also that fees collected would be embargoed, meaning they are not to be spent anywhere else in any agency, including Commerce, in which the Trademark and Patent Office are nestled. That means that there is an obligation to raise enough funds to modernize the Patent Office. Federal workers are stressed today in the Patent Office because they currently do not have the tools to keep up with the demand. In 18 human hours, 17-18 human hours, the question is do we get it all right on a 1,000 claim, including dependent claim patent applications, and the answer, of course, is no. One of the goals set out by the Director which I completely agree with, and I believe everyone on the dais does, is that we have to work hard to continue to sustain or improve patent quality. I say sustain because as they become longer, if we do not have the tools to allow patent examiners to do their job, or if, in fact, we do not supplement technologies that may not be available to the examiners, and I say that specifically because historically, the examiners are skilled in the technology they are evaluating. Many of the technologies are so short of people that, in fact, to recruiting those people or to train them in emerging technology, is virtually impossible. That means that not only do we have to embrace AI in the patenting process, but we have embraced AI in the Patent Office. This will cause the Patent Office to spend vast amounts of money, whether it is done in concert and collaboration with other AI companies or substantially an in-house production. It will cost a great deal to produce and maintain. However, when in the foreseeable future we are dealing with more than a million patent applications a year, more than half of which come from countries outside the U.S., the largest of which is China, a country that does not respect the rules of how we create and qualify inventors, we are going to need sophisticated tools to spot whether, in fact, true invention is being submitted to us. Implementing the President's Executive Orders is going to be a daunting task. Fortunately, he has selected someone that is highly qualified, someone that has the respect in the Senate, particularly, of both Republicans and Democrats and I believe today you are going to see that we are very pleased with your selection. That does not mean, Mr. Squires, that we are pleased with everything that is going on. Recently, you had to deal with a clear conflict of interest, but also with a policy that was ambiguous as to where a conflict lies. The particular case does not need to be discussed here because it has risen to criminal activity and a dismissal. Let's understand, patent examiners, with even a small amount of stock, cannot and should not be evaluating a patent that could benefit that company or that stock. That level of conflict of interest now is zero under your leadership, and I want to particularly commend you for that. If somebody had asked me, as someone who has followed the Patent Office for decades, if that was the policy I would have said well, of course it is, only to discover that in my entire career both in and out of government it was not. Again, I want to commend you because that is the kind of hands on decisionmaking that we need to have. Additionally, I want to make it clear the President has an agenda. That agenda is not in conflict on either side of the dais. That is that although sometimes when you say MAGA is pejorative in this body, that making America and keeping America great is the goal of every aspect of this body and of the Patent and Trademark Office. Onshoring of manufacturing of all sorts, mining, agriculture, conventional manufacturing, and yes, intellectual property manufacturing, is not just the goal of this administration, but it should be the goal of everyone that wants America to have 250 years that, in fact, resemble the first 250 years. Therefore, any policy that isn't helping and supporting the ability for companies to make a decision, whether they be U.S. companies or global companies located outside the U.S., to make, use, and sell in the United States is adverse to the President's policy and adverse to the best interests that we on this side of the dais enjoy. That brings up a particular point, and it is one that I think is important. Under the policies of Acting Director Stewart and quite frankly, as far as I can tell, the continued policies, I see a real threat to that. At the end of the Biden Administration, there were approximately 280 slots for patent examiners under PTAB. My understanding is that more than 80 of those slots are now vacant. The systematic change from 80-90 percent of PTAB reexaminations being granted to just the opposite, somewhere in the neighborhood of 80 percent being rejected, including a policy in draft form that I will push back on is not within the discretion and I repeat, not within the discretion of the Patent and Trademark Office, is one that determines that if a patent is beyond a certain number of years, it simply will be automatically discretionarily rejected. I was here and some others on the dais who will talk today, we were here on a bipartisan, bicameral basis under former Senator Leahy. We came to a compromise. That compromise was worked out by parties far and wide, not to everyone's complete satisfaction, but to overwhelming support. That meant that PTAB did not completely displace ex parte reexamination, that it still has a valid use. It also means that the so-called one and done was never in place. To compromise between one and done which was asked for by a number of companies, not the least of which were the leaders in bio and pharma, we said that if you get past the first reexamination, which was assumed, if it came in with credible arguments, would go through reexamination, that it would be discretionary thereafter. The law was unclear and I have to take some credit and blame for that, that when you look back it doesn't actually say that the first one will automatically be more favorably considered, but the intention was clear and the spokespeople on both sides of the capital and on both sides of the aisle were speaking specifically that the bias would be toward yes on the first one and then there would be a higher standard when either the same company or another company came in with substantially the same information based on substantially the same patent accusation. I say that because, obviously, sometimes you have diverse and different views. One of them, for example, is one patent that has been asserted against Intel Corporation and Gillette for razors. I have to believe that the arguments in why that would be invalid, unsupported, or unin-fringed could, in fact, be different between a microprocessor and a razor. When I was shaving this morning, that was all I could think about was what could possibly be different? The reality is we have to balance that and Director Squires, you have the hardest job. You have to balance that with a reasonable expectation that a patent is what it says it is. The question is are patents, in fact, not of the quality we would like them to be? I am going to opine for a moment that if patents tomorrow became perfect and in no case was there any ambiguity, it would still be up to 26 years before the last bad patent could no longer be asserted against somebody for damages. That is a long time. Director Squires, if you manage to serve that long, you will clearly be the first. That means that we have to continue dealing with the legacy of the past with periods of time in which new technologies came in, they were not fully understood or, in fact, on occasion, one examiner is loose. We will always have to deal with the reality that somebody will get a patent which means X and then assert it maybe against Intel and Gillette as though it means XYZ and the like. This is not something that often is done well in Article III courts. Article III courts, when I arrived here before the patent pilot legislation and before modernization including PTAB, were running as much as 40 percent reversal at the Fed Circuit. The Fed Circuit was taking an amazing amount of cases because it was almost a coin flip. We have been working to reduce that, and I must tell you we are down to about 35 percent. It is not an easy job because Article III judges, all 677 of them, almost exclusively come from nontechnology background. They are prosecutors. They are public defenders. They are civil lawyers, but they are seldom patent attorneys or knowledgeable in intellectual property. That is not their fault. On top of that, for more than half of the Judges, they will be lucky to get one patent case--let me rephrase that. They will be unlucky to get one patent case. It will be their first and after that, they will try to find another Judge to take their patent cases. That means that the first Markman is their first Markman ever. It is a technology they don't understand and a patent that says things that have to be explained to them. That is not true with the PTAB. The 200--now 180, but once nearly 280, patent examiners are technical specialists. They will look at dozens of cases, both sequentially and in parallel. They adjudicate these over a year, so by the time they have been on the job for a couple of years, they have done 60 or 70 patents. They have brought them to a close, and they seldom have any reason at all not to meet their deadlines. That means they do a better job. The proof of that is that they run about a 12 percent total reversal even in part, meaning if you lose to the Patent and Trademark Office or you win, you can pretty well take it to the bank and either move into Article III or move into another place with that patent. That means that we have to find a way to reinvigorate the Patent and Trademark Office. As I go through my questions today, I will be asking exactly that to the Director, how do we restore the ability for people who have been accused of patent infringement to rudimentary, particularly on the first time it has been asserted, be able to get in front of an examiner? There are other problems in the law that I want to make clear. We never believed that it would be 100 percent discretionary. We believe that the Under Secretary would, in fact, at the end of the day be reviewing the work of those Judges and expected there to be a process if there was a disagreement. Under Trump One, we discovered that, in fact, one person could without any explanation simply overturn a decision by an Article I judge. That still becomes a bit of a problem, and I know we will hear from Director Squires about how he is determining that and handling it. Additionally, we have discovered that a full trial that is nearing its one year, it is ready to go to decision, can in fact be pulled back and undone. Director Squires, I have to tell you it is my belief and it will be my legislative last act if I can that this either will be undone or we will undo it. Once a process, a determination is begun, even if you at the end of it all choose to not agree with the decision to undo it, to in retrospect undo it is, in fact, to have less than the fair process be appeared, and in fact both parties have spent money in the process. It should be allowed to go to decision. You can then evaluate the decision. That is of particular concern, and it will be the one that I spend most of my time on. Last, on the dais, there will be people who don't know the meaning of trolls, and there will be people who don't know the meaning of trolls. It is a difficult guess. There are nonpracticing entities who are great inventors, who invent things sometimes that have exactly one customer. That does not invalidate the ability for them to take their invention and say if you would like to use it, you will, in fact, have to work out a royalty. At the same time, there are nonpracticing entities who are simply in the financial gain business. Unfortunately, third-party funding has made it very possible to buy old patents, particularly those that have been around for more than six years and assert them either for the first time or for the first time against a particular defendant. That means that any deadline, any time out that says a patent can no longer be considered, cannot possibly be accurate, not because fair warning shouldn't cause someone to use a process earlier, even if not accused, I share with many that view. However, you don't know you are going to be sued in many cases until somebody redefines what that patent means. Again, in closing, I am going to back to, if you looked at a patent, any one of you in this audience and thought that it applied to Intel and Gillette, please raise your hand. If not, then in fact, that makes my case that you cannot know that your patent is going to be asserted against you in a particular way until it is. Without, at least, a constructive notice, a letter from the inventor or the like, you really are not on notice. That is why we have laches, but it is also why 6, 8, 10, or even in the 20th year we may need to use the ability to properly find out if, as asserted, the patent is valid and enforceable against that defendant. I have taken a lot of time. I have done so for a reason for the first and only time probably in my career. Nothing is more important to making a decision to onshore that knowing that in fact you are going to get a fair opportunity to defend yourself against patent and other legal accusations. I make the case in purely monetary terms. If 20 percent of the world's market buys here in the United States and you are currently making a product offshore, you have a 20 percent exposure in the U.S. if you lose a patent case. If, on the other hand, you make, use, and sell in the United States, even if only 20 percent ends up in the United States, you have a 100 percent exposure. Under the law, making in America gives you worldwide exposure in America. Who in the world would risk 80 percent of their market if they could make the product in a country they trust or multiple countries where they trust they would not be shut down? Unfortunately, that is the world we live in. We have to make it safe or at least predictable that if you are Intel, if you are Nvidia, if you are any of the companies, Taiwan Semiconductor, and you onshore here, you are not putting at risk your worldwide sales against a nefarious and quite frankly lengthy accusation that may or may not be valid. It doesn't mean that you don't have an obligation to quickly dispense with those that are valid, but it does mean that we have to maintain a system that typically in a year gets it, more or less, 90 plus percent right. With that, I recognize the Ranking Member of the Subcommittee for his opening statement. Mr. Johnson. Well, thank you, Chair Issa, and Director Squires, thank you for being here today. We customarily don't take intermissions between opening statements, but I would be remiss not to offer you the opportunity for at least a bathroom break. Are you OK? All right. Thank you. Directors of the U.S. Patent and Trademark Office appear before this Subcommittee every two years or so and I have had the honor of being present for many of those hearings. You are the sixth Director I have had the opportunity to talk with in a forum like this. Hearings like today, give us the opportunity not just to provide meaningful oversight, but also inform the legislative process so Members of Congress can make the best decisions when considering legislation. In the many USPTO Director hearings I have had an opportunity to experience, I have witnessed occasional policy missteps from USPTO Directors, and we have discussed administrative failures, ranging from modernization growing pains to too long examination time. We certainly have had our differences, but never have I had reason to doubt that the Director was acting independently from the President until today. There was a time when the USPTO was removed from the politics of today. Now, it has been drawn squarely into it. I am going to take this opportunity to go over a few of the concerns I have heard over the past year. Keep in mind this is not in any way an exhaustive list. Under the Trump Administration, the Patent Office's workplace morale has plummeted, likely because of the administration's layoffs which were bizarrely characterized as an attempt to save money, even though the USPTO is self-funded. You have also stood by as USPTO employees collective bargaining rights were undermined by President Trump, destabilizing your already fragile workforce. Under your leadership, the USPTO has publicly explored implementing a patent tax that by all accounts would have a devastating effect on innovation in the United States. These are just some of the few examples of the partisanship inserted into an agency that prides itself on stability. When politics begin to shape a traditionally nonpartisan agency, the result is predictable. You are at the helm of an institution that has lost touch with its mission. This lost mission is most obvious in the USPTO's cancellation of its planned Southeast Regional Outreach Office in Atlanta, Georgia. The USPTO chose Atlanta after a long process as prescribed under the law. Instead of going forward, the Trump Administration canceled this outreach to the Silicon Valley of the South and instead, opened it within USPTO headquarters in Alexandria, Virginia. American innovation can thrive only when opportunity to participate is accessible to all. By placing the Southeast Office at USPTO headquarters, your agency has limited its reach and concentrated opportunity among those already best positioned to access it. I encourage you, Director, to reconsider this move because while it may not violate the letter of the law, it most certainly violates the spirit of it. As you can see, I strongly disagree with the Trump Administration. I also believe you want to do right by those who rely on the patent system. Your notice of proposed rulemaking to reform the Patent Trial and Appeals Board reflects ideas this Subcommittee examined when I was Subcommittee Chair, and has similarities to those proposed in my colleague, Congresswoman Ross' PREVAIL Act legislation. While these administrative changes are certainly worth discussing, agency action is not the same as legislation. When the Director changes, so can agency rules. Patents exist to ensure that research and development rests on firm, predictable ground. This kind of inconsistency between Presidential administrations undermines the stability that is essential to a functioning patent system. Ultimately, these are questions for Congress to decide, not the agency. They are questions I look forward to addressing if I became Chair of this Subcommittee in the next Congress. A healthy USPTO requires clear rules, consistent leadership free from political influence, and a steadfast commitment to protecting those who take the risk to create. It is incumbent on us to get these questions right because inventors and job creators are not asking for favors. They are asking for a predictable and stable system they can rely on. When policy shifts with the political whims of an administration, it is American innovation that pays the price. I yield back the balance of my time. Mr. Issa. I thank the gentleman for his brevity, and as I go to the Chair of the Full Committee, I might note that apparently Mr. Johnson is considering a party change, so I hope you will favorably consider him to replace me in the next Congress, and I recognize the Full Committee Chair. Chair Jordan. No one can replace you, Mr. Issa, that is for sure. I just want to thank the Chair for this hearing and I want to thank the Secretary and the Director, those titles, for being with us today and answering the Committee's questions. The record will show after the comments of the Ranking Member that the Chair's comments were the most brief--I haven't heard from Mr. Raskin, but I will bet it will be a little longer than my opening statement. With that, I would yield back. Mr. Issa. I thank the gentleman. We now go to the Ranking Member of the Full Committee. Mr. Raskin. Thank you, Mr. Chair, and I will be somewhere in between the Chair of the Full Committee and the distinguished Chair of the Subcommittee. Thank you, Director Squires, for joining us today. As head of the PTO, your job is to promote stability in the market for goods and services by protecting trademarks that are used in interstate commerce. In pursuant of the mission, the USPTO has for decades been removed from political intrigue, favoritism, and controversy by keeping politics out. Prior Presidents and USPTO Directors ensure that applicants had a fair and honest system to rely on. It seemed to change last year. You and President Trump injected partisan politics into the work of the PTO from working to strip trademark examiners of any right to collective bargaining, a right that they had enjoyed for many decades, and firing the Members of the Patent and Trademark oversight bodies to refusing to respond to congressional requests for information. Your tenure seems to be threatening the traditional integrity and nonpolitical nature of our system. You recently took an extraordinary and unprecedented action. Earlier this year, the USPTO itself filed trademark applications on behalf of Donald Trump's ill-defined, private, multibillion global project called the Board of Peace. President Trump has declared himself Chair for life of this illusive entity. He has promised billions of dollars from the taxpayers to the board, although Congress has not voted a single dollar for it. He has secured billions of dollars from mostly corrupt foreign governments including Saudi Arabia, Kazakhstan, Azerbaijan, the United Arab Emirates, Morocco, Bahrain, Qatar, Uzbekistan, and Kuwait. Beyond that, there is not much we know about this shadowy venture. We don't know its basic corporate structure. We don't know whether it is registered anywhere in the United States or in any other country. We don't know who controls the billions of dollars in its bank accounts. We don't know what countries those bank accounts are located in. We don't know who will conduct audits and oversight of the board, if anyone. We don't know what the President intends to do with this massive, secret, unaccountable slush fund while he is in office and after he leaves. When the Board of Peace decided it wanted to secure a trademark for its name and for its logo, a move that should have required it to identify the legal entity that actually runs it and controls its billions of dollars, you stepped in. You personally filed the trademark applications allowing you USPTO to stand in as a straw trademark holder to cover up for this slush fund that appears to put both billions of U.S. taxpayer funds and billions in payments from foreign governments into the pocket of the Chair for Life Donald Trump who will control it. The President set up a board that likely violates both the foreign and the domestic emoluments clauses, and now you are helping to run the operation as far as we can tell. What is more, I am not sure either you or the Trump Administration realize what you are confessing by filing a trademark application. You are admitting that the Board of Peace is not a legitimate governmental body, but rather a commercial enterprise set up by President Trump. Our trademark law began in 1879 when the Supreme Court struck down a trademark law that applied to any and all organizational designations. The Court ruled that Congress could do so only under the Commerce clause. When Congress passed the Trademark Act of 1881, it was written to apply only to marks used in interstate commerce. The modern version of the Lanham Act in 1946 makes clear it only protects trademarks used in interstate commerce. Section 1052(b) specifically forbids the registration of any insignia of the United States or any State or municipality or any foreign Nation or any other governmental body. By filing for a trademark, you are admitting that the Board of Peace is not really a governmental entity at all. It is a purveyor of influence operating for profit with apparently a billion-dollar admission fee, at least that is what has been reported in the press. A money-laundering scheme to pocket the billions all made in a global shakedown in the name of peace. Now, as far as I can tell, the USPTO has just nine trademarks. Four are various logos for your office, some of which read USPTO, others have the full name of the agency written out, IS Patent and Trade Office. Three more are for the phrases Go for Real, and You're Smart Buy Smart, phrases that were part of a public awareness campaign that the USPTO itself ran with the National Crime Prevention Council. The other two are now for the mysterious Board of Peace which has no organizational relationship, I believe, whatsoever to the USPTO. By agreeing to act as President Trump's Phone a Friend and using the PTO to register a trademark on behalf of a third party, it would seem you are violating a cardinal principle of the Lanham Act which explicitly lays out in Subsection B that only ``a person who has a bona fide intention under circumstances showing the good faith of such person to use a trademark in commerce who may request registration of the trademark.'' That is quite a problem for the agency whose role it is to administer and police the registration of trademarks and to administer disputes about them. One can only imagine this decision will be challenged. There will be litigation over the mark that you have now claimed as your own for the PTO before your agency which is charged with being the neutral adjudicator of disputes about trademarks. The only reason anyone ever registered a trademark is to prevent competing uses. Why would the Trump Administration tell you to file for this registration except to suppress anyone else's trademark related to the word peace? The field is crowded with existing registrations by other educational purveyors of global peace. To give a few examples I found online this morning: World Peace Table, World Peace Network, Project Peace, Peace Vision Global, Global Peace Initiative, Global Peace Foundation, International Peace Center, Peace Network, Peace Action, the Peace Trust, and Greenpeace. Any one of these organizations would have a strong case to sue for cancellation of Trump's Board of Peace trademark on the grounds that it dilutes and infringes their own preexisting trademarks for peace facilitation services. Also, of course, that this mark is not registerable at all since it purports to identify a governmental entity and not an organization in interstate commerce. Now, only would you have to decide whether Trump has a defense to prior users' opposition to his marks, you would have to rule on any offensive use of trademark law by Trump against any of the other groups. Let's say he moves to attack Greenpeace for infringement of his commercial trademark or opposes registration of any new organization that uses peace in its name. Who would adjudicate this? You would, your office. You are both the owner and you are the judge of any rights that you have as an owner against anyone who wants to identify their organization with the word peace. This is not just a disreputable use of the trademark registration process; it is the first step in giving Donald Trump and his subordinates a monopoly on use of the word peace to make the very notion of peace unthinkable that departs from control of the new big brother who now owns it. If President Trump can't win the Nobel Peace Prize he craves because he plunged us into an aggressive toward the Middle East, now he will just own the word peace instead. I wrote to you last week, Director Squires, asking about this illusive entity and unprecedented baffling situation. If there is a reasonable explanation for the USPTO's conduct here, we would like to hear it today because if you simply filed on behalf of the Board of Peace as a favor to the President, then that is a serious problem. A decision like that doesn't just drag the USPTO into covering up for a slush fund that may violate both the foreign and domestic emoluments clauses, it is bad for the integrity of our trademark laws. When people lose faith in the fairness and objectivity of our system, it begins to fall apart. I am not just troubled that you may be violating the basic trademark rules. I am troubled that in violating the rules to help Donald Trump, you may be acting as a political operative in a way that will destroy our neutral system for regulating source identifying trademark rights. The trademark system is designed to protect everyone. If applicants think that the rules change for the wealthy and the politically well-connected, they are much less likely to believe the system can work for them. I look forward today to finding out how you justify your agency registering a commercial mark for this alleged governmental entity, if that is what it is, how you intend to resolve disputes with the dozens of past and future registrants of peace organizations and what you intend to do to restore the professional nonpartisan reputation of the USPTO. Thank you, Mr. Chair, I yield back. Mr. Issa. I thank the gentleman. Without objection all other opening statements will be included in the record. Before I introduce the Director, I would ask unanimous consent that we place into the record the Wiki delineation of the Voice of America which is a U.S. Government owned international broadcast with trademarks including Voice of America, VOA, VOA News, et cetera, which is owned by the U.S. Government and was trademarked in 2007. Without objection, so ordered. We now introduce the Hon. Director of the Patent and Trademark Office, the Under Secretary of Commerce for Intellectual Property and the Director of the Patent and Trademark Office. Prior to joining USPTO, Director Squires was a partner and Chair of IP at emerging companies' practice, particularly Dilworth Paxson LLP which is a longer name than when they had three names instead of two. We welcome our witness here and thank him for appearing. Pursuant to the rules, I would ask you to stand and take the oath. Do you solemnly swear or affirm under penalty of perjury the testimony you are about to give will be true and correct to the best of your knowledge, information, and belief so help you God? Thank you. Let the record reflect the witness answered in the affirmative. Director, our normal rule is five minutes. Considering the Ranking Member and myself, I will be lenient if you go over, very lenient. Since you are the only witness, we came here to hear what you have to say. However, your entire opening statement, if you don't use it all, will, in fact, be placed in the record along with any other supplemental information you choose. You are now recognized. STATEMENT THE HON. JOHN A. SQUIRES Mr. Squires. Thank you, Mr. Chair. Chair Issa, Ranking Member Johnson, Chair Jordan, Ranking Member Raskin, and the Members of the Subcommittee, good morning. Thank you for this opportunity to discuss the USPTO's operations and initiatives. I thank President Trump for his confidence in me to lead America's innovation agency, and for his steadfast commitment to intellectual property, reaffirmed yet again with his national AI policy framework released on Friday. It is also the honor of a lifetime to serve Secretary Lutnick, a phenomenal leader with boundless energy and unparalleled experience, himself an inventor on nearly 500 patents. I am honored today to provide the Subcommittee an overview of the USPTO's recent activities and accomplishments. America's innovation agency has two founders. For patents we have America's Invention Agency, and for trademarks we have America's Branding Agency. Together we function as the Department of Commerce's central bank of innovation. Every unit of intellectual property we put into circulation is a potential job, a new business, a competitive advantage, an investible asset, a lifesaving drug, all flowing into the real economy, into the real world. In its scale, American ingenuity means national prowess and global reach. I can't thank USPTO's highly educated and talented workforce enough for their dedication and commitment. I say to everyone they are the best in the world at what they do because, quite simply, they are. None of this would be possible without the fee setting authority so thoughtfully provided by Congress, allowing us to operate like a business, maintain long-term financial stability, and achieve our statutory mission. We also greatly appreciate the continued authority to spend anticipated fee collections which lies at the heart of our U.S. global leadership. We look forward to working together to maintain both it and our global lead. Indeed, we lead today because our Founders did the extraordinary two centuries ago, enshrining IP protection into our Constitution and, with it, the American experiment itself, the American experience itself. Last month, I told the head of the UKIPO how our constitutional charge allows us to lean into AI, to quantum, to medical diag- nostics, wherever the onrush of technology is going. His candid reply: I know. Wish I had that. Think about that. The very empire we won our independence from, two democracies, two outcomes, but only one clearly atop the IP world today. That is why it is incumbent on the USPTO to have an America First IP agenda, build atop a unique legacy our Founders bestowed on us. We are doing exactly that with the urgency of now. As I am before you today, our first priority was slashing the unacceptable backlog by 50,000; another 100,000 to come this year. By the end of my tenure, and with your continued fee setting authority, choking backlogs will be a thing of the past, and improved quality a confidence indicator. I am confident because we just announced our first agentic AI trademark classification tool. Five months of manual searching is now a five-second outcome. In patents, our AI search system delivers a top ten list of prior art before the first office action, providing quicker pathways to allowance. Across both, AI fraud protections helped us purge 70,000-plus baseless filings in just under a year. You see, AI tools will become our, our examiners' superpowers, supplying them with a cadre of agents to deploy as they see fit. On policy, Congress affords us discretion. Our North Star to its exercise is always both the letter and the spirit of the AIA, balancing, as instructed, economic impact, resource efficiency, and the integrity of our IP system. We are restoring balance and fairness on both the front ends with eligibility determinations, and the back end as to trials and error corrections with new feedback loops in between. Mr. Chair, I am humbled and proud to lead this unique and vibrant agency. We are back on our front foot and delivering the brilliance tomorrow's American ingenuity affords, tinker by tinker, breakthrough by breakthrough, dream by dream. Just as a Central Bank stabilizes the flow of capital into the real economy, the USPTO stabilizes the flow of innovation into the knowledge economy. With Born Strong protection, new ideas can blossom in a marvelous virtuous cycle that has delivered prosperity and bettered people's lives for over 250 years like no Nation before, like no Nation ever. Thank you again, and I look forward to your questions. [The prepared statement of the Hon. Squires follows:] [GRAPHICS NOT AVAILABLE IN TIFF FORMAT] Mr. Issa. Briefly, so very brief. Thank you. We now recognize the gentleman from Kentucky Mr. Massie for five minutes. Mr. Massie. Well, the last Member of the Administration that I was very nice to was Kristi Noem. She was removed 48 hours later. At that risk, I want to thank you for the great job that you do. I would like your analogy of intellectual property to currency. Let's don't compare the Central Bank to the Patent Office because some of the Founders, all of the Founders were unanimous in understanding that the patents and copyrights were the foundation that would allow our country to grow. I appreciate you doing that. It is an appropriate analogy because of intellectual property to currency because we have had a crisis in our currency over the last decade, I believe, of intellectual property. If your currency is called into doubt, if the Federal Reserve Notes in your wallet when you present them, even though they were issued by the government, if they are called into question when you try to use that currency, you have a problem. That is the way it has been with patents. The PTAB ostensibly was created to make it easier to adjudicate validity on the back end of a patent issuance and enforcement. The problem is it has created too much uncertainty. I very much appreciate the steady hand that you put on the tiller. I would disagree with my Democrat colleague who said that policy shouldn't change when administrations change. I would argue that elections should matter. Laws should not change. The patents that have issued should not change, they should still be valid. We need somebody in charge. We need somebody to exercise commonsense in the application of the laws that we have passed. It seems to me that you are doing a very good job of that. Could you tell us about the rule that you are proposing and the actions that you have taken in terms of exercising discretion on the IPRs? Mr. Squires. Thank you, Congressman. I am happy to speak to the notice of a proposed rulemaking we have put forward. Basically, it is intended to restore fairness and balance to the IPR process. There have been instances where there have been as many as seven serial filings. It is intended to be able to have the matter adjudicated once and for all early. It has been termed, I will say, as one and done. That is a misnomer. There are liberal joinder provisions that are carried through into the rule. I would say it is one join and done. The facility is provided for if there is a petition filed after there has been an adjudication that-- excuse me, petitions filed, people can join. The answer isn't serial filings. We think the answer should be gang tackling. At the time it wasn't to be had. The preference would be to have a PGR-like process where things are laid open. That is not always possible. As has been discussed, things sneak through. There should be a point in time where there is quiet title, there is finality, and people can have that chance and do it together, but it has got to be adjudicated once and for all. Mr. Massie. I agree. Once you have the imprimatur of the government and you have survived a challenge that is important. Because what I have noticed in the last 10 years, a lot of people are shying away from companies that would have been based on intellectual property. I have people, inventors, say I am not even going to file the patent, I am just going to try to rely on trade secrets. That creates a world of haves and have nots when everybody can just keep all their stuff secret and that is incentivized because of a patent system that is not working. The PTAB, I do think it was probably, at least from the people who voted on it, originally intended to expedite this adjudication. It has created uncertainty that has hurt our country, hurt our inventors. I am glad to see that you are exercising some commonsense in the application of it. Any law can be weaponized. We saw that the PTAB law has been weaponized. I appreciate you taking it back and using it for commonsense. I will give you my last 15 seconds. Mr. Squires. Thank you very much, sir. Also, to be reminded, there--IPRs are but one avenue. There is always reexamination. There are post-grant reviews of the District Court. What we had found was, particularly with respect to IPRs, that it was intended to be an alternative to litigation, yet 80 percent of the filers already had a District Court action with also doing an IPR. Mr. Massie. Thank you for taking out much of the redundancy that existed. Because it doesn't get cheaper when people keep getting subjected to continuous IPRs or to survive the IPR and then go to court. I will yield to Mr. Issa. Mr. Issa. Thank you. Just to clarify, that 80 percent includes a dramatic amount who have been sued and then come to the Patent Office, because that is the first notice of infringement is when they are sued. The chicken or egg often starts with a lawsuit and you go to the PTAB to shortcut the time it takes to show invalidity. Correct? Mr. Squires. Yes, sir. There is a one-year window if you have been sued in District Court from which to avail yourself of the point. Mr. Issa. Thank you. I now recognize the Ranking Member of the Subcommittee for five minutes. Mr. Johnson. Thank you, Mr. Chair. Director Squires, I hope that you will agree with me when I say that the greatest asset of the USPTO are its employees. Employees at USPTO have described the environment as ``rife with rumors, paranoia, and disillusionment.'' Just last week in a governmentwide survey, only 13.8 percent of PTO employees reported that they were satisfied with their job. What factors have contributed to such dissatisfaction by your employees? What specific actions have you taken to address this collapse in employee morale? My office received a call just the other day echoing these and other troubling allegations. What mechanisms are in place to ensure employees can report issues without fear of retaliation? Mr. Squires. Thank you, Congressman. We have robust facilities for reporting violations through our EEOC department. They are fantastic as to examiners. I do agree with you, they are the crown jewel of the USPTO. They are the best in the world at what they do. We are trying to make even better equipped to deal with the what has become a crushing backlog of work that they have so dedicatedly and assiduously have chipped down on. We have increased awards, financial awards for examiners. We are working on the personnel. I have myself-- Mr. Johnson. What factors have contributed to the dissatisfaction that is evidenced by the survey? Mr. Squires. I am equally interested in making sure morale improves and have offered engagement. My, I think the biggest factor has been the backlog getting out of control. It rose to a historic high of 837,932 applications unexamined. This is just unacceptable, as the Secretary had said. Mr. Johnson. It is not the volume in and of itself, but it must be something that the agency has done to address that this has caused the lack of morale, or morale to plummet. What are those factors? Mr. Squires. The specific factors, we just concluded an employee survey last week and we will be working on those and examining them. I, myself, hold, host a, I am using I did them weekly, now monthly, for people to tell us what they think. That has been my mantra coming in. There's forums for people to tell us where there are problems. One of the issues that has been unhappy that caused some unhappiness has been not deploying people on the frontlines, the primary examiners and having oversight and training and not having signature authority at that point in time. We have found that this is the first interaction that the applicants have had with the office. Supervisory has been very important. It is consistent with other international offices. There has been some adjustment to that. There is some initial unhappiness with that, but we have been at that now for over six months and I think morale is getting better. Mr. Johnson. OK. I am going to move on. After the success of the four regional offices created in the America Invents Act of 2011, Republicans and Democrats worked together to pass the Unleash- ing American Innovation Act in 2022 to establish a Southeast regional outreach office, among others. Atlanta, Georgia was chosen as the Southeast location after a lengthy process. Last year the Trump Administration reversed course, announcing that the Southeast office would instead be at USPTO's headquarters. This change was announced with no explanation, and no search process was conducted, as required by law. Director Squires, regional offices were created to expand access and reach a more diverse set of stakeholders on a more local scale. How does placing the Southeast regional outreach office at headquarters advance that mission? Isn't it true that placing a regional outreach office in the literal headquarters of the PTO undermines the very purpose Congress had in creating it? Mr. Squires. Congressman, that decision, of course, was made and effectuated before I took office. I took office in September. However, my ongoing responsibilities are, as you have indicated, access, making sure there is access. Now, we have little compliance with the regional office footprint in having four. We recently had five and the Denver office was closed down, resulting in savings of over 3.8 million per year. Savings are not the issue, access is. In favor of that we have launched a Community Engagement Office model. We have just released a Request for Comment to the Southeast region, including Georgia, including all the States that were part of that defined region. We have had great success with the Mountain West region in this, to the tune where we are able to increase access, engage with universities, widen our footprint, and be able to do it at little or no cost to the office. We are moving to a model of the future. We are hopeful I-- Mr. Johnson. You are doing it based on executive authority, undermining legislative authority. That is a trend in your agency that is upsetting. With that, I will yield back. Mr. Issa. I thank the gentleman. I am going to just join the queue on one thing. Director Squires, would you agree to have a separate lengthy briefing for the Ranking Member and myself on that plan, how it is to work, and how it can accomplish what was legislatively in place? I, for one, would not want to see San Jose closed for savings purposes, no matter how it might be without congressional approval. Would you agree with that? Mr. Squires. We would be happy to work with the Chair and the Ranking Member. Mr. Issa. Then we will make that arrangement. We now go to the gentleman from Wisconsin for five minutes. Mr. Fitzgerald. Thank you, Chair. Director Squires, thanks for being here today. Last Congress I introduced legislation to limit the enforceability of patents by entities on certain national security-related sanctions lists. This is because I believe, I think many Members believe, State-sponsored entities like Huawei can and do use protected patent litigation to slow or stop critical technologies from being developed in the U.S. Do you see that as the present or future national security threat? Where do you stand on limiting enforceability of patents in those types of cases? Mr. Squires. As to limiting enforceability, one thing I would point to is we recently--a couple things in the PTAB. We restored the real party-in-interest requirements. With that, we just issued a decision called Tianma last week which includes under the AIA, as with American Government entities and agencies are not persons and cannot be in the PTAB, neither may foreign sovereigns or State actors. If a real party-in-interest is identified they are not allowed to be in the PTAB and they can't bring challenges. To protect, with that, in the discretion of instituting IPRs we have also just released guidance that look to whether it is a small business in the U.S. or American manufacturing, manufacturing that is occurring in the U.S., as part of whether a challenge should be instituted, so to protect American manufacturing and have them choose here. Both sides of the equation we are trying to take into account what the real world is. The process for filing a petition we say tell us your story, and so we can take these into account. Mr. Fitzgerald. Another area where I know many Members have concern about foreign exploitation. It is all about the patent prosecution highway, right, as it is referred to. Under this program the USPTO will expediate review of certain patent applications that have received a favorable exam in a foreign patent office. We know that China participates in the program and, therefore, an entity like Huawei could receive expediated examinations of its patent, so long as it first gets a favorable exam in China, which is effectively a rubber stamp; right? Should we not allow, or shouldn't we be concerned, I guess, about the way that is playing out? Mr. Squires. Thank you for the question, Congressman. That is of great concern. It is a bilateral concern. In general, when cases come in through the patent prosecution highway they have already been examined, but there always is the risk of rubber stamping. We do an independent analysis. If it doesn't pass the smell test, then we kick it and it goes back in line and the prosecution is lost. On the other side, we found for U.S. companies the PTH has helped them in other countries. We are trying to always maintain that balance where American companies going into other offices are receiving a favorable treatment. They have behind them the examination that has occurred and, hopefully, Born Strong in the U.S. Mr. Fitzgerald. Right. Mr. Squires. We are always on the watch for incoming low- quality patents. Mr. Fitzgerald. Very good. Let me quickly turn to kind of another area. According to American Intellectual Property Law Association the average cost of patent litigation in a District Court is $5 million, whereas the cost for adjudicating patent disputes before the Patent Trial and Appeal Board on average is about 10 times less, or around a half a million dollars. Critics of the proposed changes to the PTAB process have said the result will be more patent cases being litigated by the courts. Assuming that could be true, did the USPTO take into consideration increased litigation costs when conducting an economic analysis of your IPR rule? If you didn't, then how did you handle that, and why didn't you maybe look at that? Mr. Squires. Thank you for the question. Yes, we have. We are taking, we are still in the process of finalizing the rule. We have received over 11,800 comments, which we are very excited about because people care. About 2,800 were unique clearing out all the me too ones or, clearing out the ones that are we don't like the Patent Office. Substantively there are about 2,800. By under the AIA we are required to consider economic efficiency, resource allocation to the office and effects of that sort. By all means we are looking at what the costs are in the rule. I am optimistic the rule will be finalized. I believe people will be very happy with the outcome. Mr. Fitzgerald. What around judge's caseload, did you take a look at that as well? Mr. Squires. Yes, we are looking at all that in the rule. Judge's caseload, but it is also not just District Court forum, what is the effect on reexamination, and what is the effect on PGR, and what is the effect also on ITC cases. Mr. Fitzgerald. Thank you. I yield back. Mr. Issa. I thank the gentleman. My understanding is it was about nine to one opposing the rule in that 2,800: 2,500 to about 300. Sound about right? Mr. Squires. Again, we are still working through it. I have seen those numbers. I have seen 97 to three. I have seen 80:20. Our role under the rulemaking process is we go through and respond substantively to comments. Comments have been very helpful. Again, I am of the firm belief that we are going to see a rule that will be workable. Mr. Issa. OK. Hopefully, the Ranking Member of the Full Committee has read all 2,800 and can opine on what he saw as the ratio. I recognize the gentleman from Maryland. Mr. Raskin. Mr. Chair, thank you. Director Squires, how did you come to file those trademark applications for the Board of Peace? Mr. Squires. Thank you for the question, Congressman. We came to file, I had them filed in response to an immediate cybersquatting land grab of the domain name. For those who are unaware of the term cybersquatting, it is like identity theft. Mr. Raskin. Sure. Were you acting as a lawyer for the Board of Peace at that point? Mr. Squires. No. Mr. Raskin. In what capacity were you acting? Mr. Squires. Well, the Board of Peace, this is exactly the issue. I am glad to have the opportunity to explain it and respond to your letter. Mr. Raskin. Please. Mr. Squires. The Board of Peace has not yet been formed as an international organization. The cybersquatters eight minutes into the President's speech announcing it registered the domain name. That is-- Mr. Raskin. Is it a public entity, the Board of Peace, or is it a private entity? Mr. Squires. At this point I am not sure if it is formed or not. We acted as a custodian, so that they could have the mark-- Mr. Raskin. How did you come to act as a custodian for that trademark? Mr. Squires. Under 35 U.S.C. 3 it is my responsibility to advise the President through the Secretary of Commerce on matters of national security and all matters of intellectual property. That is the-- Mr. Raskin. The Board of Peace is a public entity, it is a governmental organization even though Congress has not created it? Is that right? Mr. Squires. Sir, I don't know the status of whether it is an entity formed or not. Mr. Raskin. OK. Well, how did you get involved in it? Did the President call you about the cybersquatting incident? Mr. Squires. No, the President did not call me. It came up through several organizations about the cybersquatting. The action needed to be taken to address the harm. Mr. Raskin. When you talked about the cybersquatting you noted that there were lots of other organizations that were already using some variation of Peace Organization, Peace Committee, World Peace, and so on; right? A dozens of them. I found them this morning just on the way in. Mr. Squires. Well, again, reference was made to shakedown. This was registered, this particular boardofpeace.org. Without that you don't have-- Mr. Raskin. You registered that? Mr. Squires. No, no. Mr. Raskin. Oh, who registered? Mr. Squires. A cybersquatter did. Eight minutes into the President's speech. Mr. Raskin. Oh, but you don't have to talk about a cybersquat- ter, there are dozens of other groups that have peace in their name; right? Well, look, where did your legal authority come from to file trademark applications on behalf of this Board of Peace, whether it is a public or a private group? Mr. Squires. It comes from the combination of 35 U.S.C. 3 and 35 U.S.C. 2 under the Lanham Act. In your opening statement-- Mr. Raskin. Well, wait. Do you usually act as a custodian for the intellectual property rights of other entities or is this just for President Trump? Mr. Squires. This was to protect the name Board of Peace as the entity gets booted up, to act as custodian in a very narrow capacity with a bona fide intent to use the name. Then, its attempt to use application to be changed forward. Mr. Raskin. Who has the bona fide intent to use it? Mr. Squires. The USPTO. Mr. Raskin. The USPTO is. What are you going to do with it? Mr. Squires. In the very limited services that we define there, which are fraud prevention, misuse. Mr. Raskin. Is that a service you offer to all American citizens? In other words, if I am thinking about maybe creating a group one day and we might want to have a trademark, and I am afraid somebody else has a competing trademark, you will go ahead and file the application for me? Mr. Squires. My responsibilities are, again, under 35 U.S.C. 3 to advise the President on matters of national security. Mr. Raskin. So, this is a matter of national security? OK, let me ask you this. You have emphasized today, and rightfully so, the importance of people who are applying for patents or trademarks to pay a fee, because yours is a fee paid office. How much does it cost for someone to seek a trademark? When you applied for that trademark for the Board of Peace, how much does that cost? Mr. Squires. It is, it is not an expensive fee. Depending on-- Mr. Raskin. The website says 350 bucks. Is that right? Mr. Squires. Generally, yes. Mr. Raskin. It was not expensive. OK. My one of the able lawyers on my staff just passed me this, that you filed a petition on January 21, 2026, to waive that fee for the Board of Peace. Then you granted that petition the very next day, which underscores the bizarre conflict of interest you are in, now acting both as a representative of the Board of Peace and also the Trademark Office that is going to pass on the petition. Why did you seek a waiver for the $350 for the Board of Peace? Why did you grant it? Mr. Squires. The waiver was sought under the particulars of the intent to use application as the custodial filer. I did not grant my own application. Mr. Raskin. Well, your signature, as I am reading it you filed this on the 21st, and then you approved it on the 22nd. Mr. Squires. Well, I would like to see the document to which you are referring. Mr. Raskin. OK. We will get you those documents. Are you saying you would not have approved of it had you seen it? Mr. Squires. I am saying I don't recall this particular situation. Mr. Raskin. OK, but your signature-- Mr. Squires. I do believe it is in my authority. Yes. Mr. Raskin. OK, it was approved by Dan Vavonese but your signature is on the petition. I guess-- Mr. Squires. Yes. Mr. Raskin. --well, why did you request that waiver of the $350 payment for the Board of Peace? Mr. Squires. Again, given that this is going to be an international organization and given the situation with intent to use and the bona fide limited scope that we had, I made that petition just as I signed the application. It was granted by someone else. Mr. Raskin. OK. Then, finally, you know that the, the Lanham Act forbids anyone from submitting an application unless they are the owner of the mark or the legal representative of the mark. Were you representing yourself as the owner of the mark or the legal representative when you filed the petition? Mr. Squires. No. We are very clear it is on a custodial basis. We are not the owners. It will be transferred to the entity once it is formed. Mr. Raskin. OK. Well, you are listed as the owner on the petition both for the waiver and also the application. That is the way the Lanham Act works. In other words, if I am asking for your advice could I get another company to apply for a trademark for me? What is the answer to that? Mr. Squires. If you are the President of the United States, yes. Mr. Raskin. The President of the United States could have somebody else--the President of the United States has tons of trademarks. You are saying that he doesn't have to submit himself? Where does it say in the Lanham Act that the President of the United States is exempt from the general rule that you cannot have a third party seeking an application on your behalf? Mr. Squires. I am, again, directing you back to U.S.C. 35, 35 U.S.C. 3, where it is the Under Secretary of Commerce and Director of the Patent Office shall advise the President on national and certain international intellectual property policies. Mr. Raskin. Those are matters of public policy, they are not questions of representing the President before the Trademark Office which, obviously, creates a stark conflict of interest. Mr. Issa. The gentleman's time has expired, but you may answer. Mr. Squires. Sir, I was not representing the President of the United States in this regard, I was representing a--filing an application to address a cybersquatting issue under my authority under 35 U.S.C. Mr. Raskin. I appreciate it. Thank you. I yield back, Mr. Chair. Mr. Issa. I thank the gentleman. Just one question for understanding. The gentleman from Maryland mentioned a number of other uses for peace and so on. Under both common law and any marks they have, those marks are previous, superior, and are not eclipsed by this new mark. Is that correct to your understanding? Mr. Squires. That is my understanding. It was a very narrow filing for the logo and the, and the name. Again, it was an intent to use application. If nothing happens, it expires of its own weight. It just goes away. Mr. Issa. One thing, because I am a little new to government, but you are, you are in the Article II, you are in the government that is headed by one person, the President; right? No matter how many pockets you have in your suit it is still one suit jacket; right? The $350, if it had to be paid for by the government, can you tell me the difference between all these different places in the government that would transfer $350 to another pocket of the same suit? Because I am just, I am not quite understanding the gentleman's question. Mr. Raskin. Mr. Chair, are you saying that it is a governmental body in that case? Mr. Issa. Well, it appears as though the President of the United States made a statement that either it would be a Government entity or, like Voice of America and many of these other entities that are government-sponsored, it would be government-sponsored. There has been no assertion that this was a for-profit private entity or anything of the sort. Mr. Raskin. The Voice of America doesn't get a billion dollars from the Saudi Government. That would make it an illegal, unconstitutional foreign emolument. This is just getting more confusing by the moment here. Mr. Issa. I share with the Ranking Member questions of other moneys that are not necessarily associated today. I am, quite candidly, willing to participate in all the fact finding on anything related to money. The gentleman came here with tremendous expertise. Your line of questioning was very good as to how at times the Trademark Office does in fact institute protection against cybersquatting. You were also very helpful in delineating the fact that there are these entities that aren't quite government, that are government, that have trademarks, one of which is the Voice of America and many other highly recognized U.S. entities which are solely funded by the Federal Government. It has been productive. I will join with you to continue looking at questions of moneys from other governments, whether or not they are coming to the government or whether they are going to a third party because I think that is fair area. I just don't think it is within the gentleman's expertise. Mr. Raskin. All right. Well, I would welcome a thorough ventilation of all these issues just so-- Mr. Issa. Like we don't go down a dark road here. Thank you. Mr. Raskin. Thank you. Mr. Issa. With that, we go to the gentleman from Virginia, Mr. Cline. Mr. Cline. Thank you, Mr. Chair. Director Squires, third- party litigation funding allows outside investors, including foreign entities and sovereign wealth funds, to finance patent litigation in exchange for a share of any recovery with no disclosure to the court or defendant. You called foreign-backed litigation funding at the PTAB unacceptable during your confirmation and committed to stronger transparency requirements. This is an important concern. When disputes are pushed out of PTAB and into District Court, discovery becomes a weapon. Yangtze Memory Technologies, which is on the BIS entity list as a national security threat, is currently suing Micron and has used discovery to compel disclosure of highly sensitive trade secrets. Does the USPTO support transparency requirements for third party litigation funding? What role should the office play in preventing foreign adversaries from using opacity in litigation funding to drive American companies into discovery that exposes sensitive technology? Mr. Squires. Thank you for the question, Congressman. In terms of litigation funding and disclosure for District Courts, those would be my understanding would be handled by local rules and requirements. For the PTAB what we did is imposed real party interest disclosure requirements by reinstituting the Corning Optical precedent. Then, ensuring when real parties are identified and they are foreign sovereigns or State actors they are not allowed to participate in the PTAB because they are not persons, just as the U.S. Government is not considered a person in the PTAB. RPIs are critically important. They go to issues of estoppel, they go to issues of fairness, and they also go to issues where foreign sovereigns or State actors under--try to undermine the U.S. patent holders and the system. Mr. Cline. OK. Nonpracticing entity District Court filings rose 18.7 percent in 2025, two consecutive years of increases before your proposed IPR restrictions have even taken effect. Consider who benefits from that. Four of the top five U.S. patent recipients in 2025 were foreign entities. Huawei, which previously sued Verizon for over a billion dollars, has transferred nearly 1,000 U.S. patents to assertion entities targeting American companies. BOE, Tencent, and CATL, all formerly designated by the Department of War as Chinese military companies, are also among the top recipients. What evidence does the USPTO have that the proposed rulemaking will not further drive-up patent litigation costs for American innovators and manufacturers? Mr. Squires. Thank you for the question. Again, we are working through all the comments and rules, including the justifications that we are required to under the AIA such as economic theft. To your question, at the PTAB we have considerations which was just instituted in the guidelines for people to tell their story if they are American manufacturers and they are being pursued by foreign entities or these holders of patents entities in particular, foreign entities. Tell us your story and we can make sure that this is considered in instituting a proceeding or not instituting a proceeding. It works both ways. We are trying to look at the real-world picture on the ground and take that into account when a request comes for a proceeding to be instituted or not. Mr. Cline. OK. Switching to trademarks, you may know I am the Cochair of the Trademark, the congressional Trademark Caucus. I hear concerns from American brand owners about the growing backlog in processing trademark applications and the impact on the ability to secure foreign trademark priority rights under the Paris Convention. As I understand it, to benefit from a U.S. filing date under the Paris Convention an applicant has to file a foreign trademark application within six months of the U.S. filing date forwarded by a PTO-issued certified copy of the U.S. application. I am told the PTO's stated goal is to issue such certified copies within seven days, but that current processing times exceed three months. That appears to be getting worse. I am concerned that the inability of the PTO to timely process these requests threaten to jeopardize the ability of American trademark owners to claim and defend foreign trademark priority rights. Can you tell us what you are doing to reverse the disturbing trajectory of this backlog, and to ensure that the ability of American companies to protect their trademarks against foreign competitors is not jeopardized by staffing issues at the PTO? Mr. Squires. Thank you for the question. That has been a concern. It has been unacceptable as the backlog has increased. One area we have had, as I understand, and we looked into it, data processing issues that have been remedied. I have invited people to send me the request for the copies directly, and they have done so. The word has gotten out among paralegals that there is redress here. I get half a dozen emails a week which we get through. Longer term we just announced--and I think you will be happy with this--our international search classification tool which takes five months' worth of work, normally leading up to that six, down to five seconds, literally. These are going to be the sort of first agentic entry to equip our examiners with these types of tools. International search classification is just a bear, especially if you have pseudo marks and the like. The future looks very bright there. We have to make sure our house is in order and our own blocking and tackling and getting certificates out. Mr. Cline. Thank you very much. Mr. Issa. Would the gentleman yield for just a second? Mr. Cline. I yield. Mr. Issa. If I could clarify or have you clarified what you answered the gentleman. You talked about some of these protections, rules, and so on. You seem to be talking both about defendants and plaintiffs. Some of the things that I heard which sounded like protections, in fact are limitations on the defendant in PTAB proceedings. Mr. Squires. Again, the-- Mr. Issa. American manufacturing and foreign entity and the like were the question. Mr. Squires. If there is a petition filed against a patent holder in the PTAB, and part of the complexion there is that this is an action against a U.S. manufacturer, we want to know that. Tell us that and that will go to the discretionary component of the decision whether to institute or not. Mr. Issa. I understand. It is just that it also works for Huawei effectively when they have a strong manufacturer and they say, well, here it is, but it is still a Huawei patent. Mr. Massie. Point of order. How many times does the Chair get to take five minutes? Mr. Issa. I only asked the gentleman to clarify what he had answered to the other gentleman. I appreciate you can take it up at a future time if Mr. Massie is in a hurry. With that, I go to the gentlelady from California for her questions. Ms. Lofgren. Thank you, Mr. Chair and Director Squires. Under prior practice, decisions were made by the PTAB. When an IPR petition was filed a three-member panel of expert administrative patent judges decided whether to institute a review under the AIA's reasonably likelihood standard. You first centralized power over discretionary denials in the director in March 2025. Then last October 17th, your memoranda went further by consolidating authority over institution decisions in the director as well. As you know, we only have five minutes here, so these two questions really have either a yes or no answer. Do you intend to continue this policy instead of restoring that responsibility to a three-member PTAB panel of expert judges? Would that be a yes or a no? Mr. Squires. I can give you a maybe. Ms. Lofgren. OK. We would like to know further if you ponder this, because under your current policy I am wondering whether you consult with at least three PTAB judges before making an institutional decision? Mr. Squires. Yes. Ms. Lofgren. OK. That is helpful. What concerns me is not just the centralization of the authority and, therefore, potential for abuse. It is that the office now regularly denies requests through PTAB review of patents that may have been improperly granted, without giving any written explanation. I have an example. This is a denial. It is two pages, and it just says no. Right? Here is the way it used to be, which is yes or no and the reasoning. People knew where they stood. I am just sort of wondering, under the standard operating procedure manual it says the significant writing assignments in AIA proceedings include decisions on institutions. It goes on and on. The expectation is that there will be a detailed explanation for whatever the decision is. Now, I am just wondering in these bare bones summary denials where someone would find the reasoning in the arguments raised by petitioners. Do you think that practice is really consistent with principles of transparency and fairness? Mr. Squires. I do think so. There is a body of over 600 decisions that have been issued. Where there is matters of where we have something to say, or if a story needs to be told, we do issue those decisions and opinions so to provide guidance. The Revvo line of cases has been one where there have been inconsistent claims offered from District Court. There is, in fact, unsettled expectations, it has worked the other way where a patent holder had their patent lapse before it was served against the defendant. Ms. Lofgren. I would just like to ask unanimous consent, Mr. Chair, to put into the record a letter from the Alliance for Automotive Innovation, the Business Software Alliance, the High Tech Inventors Alliance, United for Patent Reform, SIIA, and U.S. Made, along with a study that really shows their dissatisfaction with the current practice. Both on the winning end and the losing end, if you don't have insight into the reasoning of the decision it is problematic. Mr. Issa. Without objection, so ordered. Ms. Lofgren. I would like to just recall creating the patent law was, the America Invents Act took a long time. It was not easy. I participated in it. Some other Members of the Committee did as well. The idea was really straightforward: High quality patents drive innovation and growth; low quality over broad patents do the opposite, they drive up prices, they impede competition, they expose businesses to abusive litigation. We designed IPR as a streamlined, expert-driven mechanism that attacks the patents that should never have been granted to begin with. It ensured the kind of efficient, targeted administrative correction that good government looks like. Now, if there are flaws with that system, we are willing to address those flaws and work through them. The agency's institution rate has lapsed, not because the petitions lack merit but there are barriers that are being applied that Congress never authorized. Just as never, Congress never envisioned that the IPR process that we crafted and are willing to work on further if it is flawed, would be supplanted by the director just seizing control of the whole operation. I see my time has expired. You have discretionarily denied 64 percent of all petitions, and the institution rate sits at about 20 percent. Mr. Chair, although my time has expired, I am looking forward to delving into this further because I do think there is a problem here, not only in the administration of the office but the lack of enthusiasm for the process among innovators in America. With that, I yield back my time. Mr. Issa. I thank the gentlelady. The gentlelady yields back. We now go to the gentleman from Texas for five minutes. Mr. Gooden. Thank you, Mr. Chair. Unlike everyone before me, I will be under the time limit. Director Squires, I would like to inquire about an IPR that was recently brought to my attention. This IPR concerns a challenge against a patent owned by VLSI on behalf of NXP, which is a semiconductor based in Texas. Based on the record, it seems this case might have been mishandled by the previous administration. Does this ring a bell? Mr. Squires. I have read in the papers about that. Mr. Gooden. OK, I will keep going. Under this IPR, VLSI's patent was challenged by two entities called OpenSky and PQA continues to be tied up in proceedings. These entities were formed around the same time VLSI won a jury trial before a U.S. District Court in Texas regarding the same patent that OpenSky and PQA challenged later. PQA and OpenSky's founders and backers remain largely unknown to the public. Director Vidal found this to be an abuse of process, but the cases were still allowed to continue. Since that Director Vidal is no longer in charge, would you happen to know who is behind PQA and OpenSky? Mr. Squires. I do not know. That is one of the reasons we instituted the RPI process. Mr. Gooden. Your answer is the same as mine because I don't know and neither do anyone I have spoken to. People keen on using the American patent system are worried about the safety of their patents, especially those in Texas. If unknown entities backed by unknown individuals start emerging out of thin air and tying up patents in endless proceedings it is not a good look for transparency and reliability of the American patent system. I believe you have been acting in the interests of promoting American innovation. I thank you for that. We would really appreciate it if you would look into this, take appropriate action, and get back to me with the answers I can't seem to find. Mr. Squires. Thank you for the question. We will look into it and be happy to speak further. Mr. Gooden. Thank you. We have also heard concerns from a lot of folks in the patent process about the lack of predictability between administrations. Is there something Congress can do or should do to help with transitions in the future? Mr. Squires. Well, one of the things that would be of great value would be to continue with the fee setting authority and fee collection authority, which will be expiring in September. We especially saw that to the dramatic benefit of our stakeholders this year with the government shutdown of 43 days. The Patent Office did not shut down. We operated on reserves because we were able to do so, running like a business from this fee setting authority. My No. 1 ask would be for that to continue. Mr. Gooden. Noted and thank you. Thank you for all the work you are doing. I yield back. I will yield to Mr. Massie the balance of my time. Mr. Massie. I thank the gentleman. Can you talk about how important it is that patent holders are able to get injunctions that the relief that comes after years of finally recovering some kind of royalty isn't enough to dissuade infringers? Mr. Squires. Thank you for the question. It is very important. We have said so now on three instances. We formed a Standards Essential Patent Working Group. Before that we have come in three cases as partners with the Department of Justice, or co-filer with the Department of Justice Antitrust Division regarding the injunctive factors. We intend to use our office as a policy voice for what is important for strong patents. To not only be Born Strong but to remain strong because they can get injunctive relief across all the factors. We filed in the ITC. We filed in District Court. I will expect to see us there to articulate the reasons why strong patents and strong injunctions for valid patents are important. Mr. Massie. Isn't it true that the situation we have now is the result of court rulings and not congressional action? Is there something that Congress could do to restore injunctive relief? Mr. Squires. We are aware, certainly, of and have looked into the provisions of the RESTORE Act, as I understand it is called, which would rebalance injunctive relief considerations. It has been hodgepodge in District Court and that has been part of the problem. Especially if you are in an arm's length negotiation and there is the holdout problem as it is called in Standards Essential patents. Having predictability would have a great market effect. The provisions, like those in the RESTORE Act, is something that only Congress can take up. We would be willing to have further dialogs as to what that might look like. Mr. Massie. Thank you. I yield back. Mr. Issa. Would the gentleman further yield, Mr. Gooden? Mr. Gooden. Yes. Mr. Issa. Just one question very quickly. You said a hodgepodge in District Court. Isn't the eBay decision a high court decision? Mr. Squires. Yes, it is. The-- Mr. Issa. The high court has ruled on injunctive relief. We live under the guideline produced in interpretation of law and the Constitution; right? Mr. Squires. The eBay case sets forth the factors which the District Courts have to apply. They have applied them in a hodgepodge fashion. Mr. Issa. Well, that is why we like PTAB. With that, I recognize the gentlelady from North Carolina for five minutes. Ms. Ross. Thank you, Mr. Chair and Ranking Member Johnson, for organizing this hearing. Thank you, Director Squires, both for your service and your testimony today. I am proud to represent North Carolina's Research Triangle, home to companies and startups that have built thriving businesses from a single idea or an invention. This type of innovation and growth couldn't happen without strong intellectual property protections that we enjoy here in the United States and that came from our Constitution. Yet, small inventors are having a much harder time defending their patents. The PTAB allows, as we have heard, multiple challenges even from the same party to a patent's validity, forcing the patent holder to defend their invention again and again, often until the patent holder gives up and settles, mostly because they don't have the resources. Not only that, but challengers often file parallel suits against the patent's validity in Federal District Court, which we have heard about, hedging their bets and hoping to get a finding of invalidity in one venue or the other. Of course, the challengers have more money to get to do that. As we know and we have discussed, the USPTO filed a Notice of Proposed Rulemaking last fall to help address this problem of repeated challenges to a patent's validity. I really appreciate Mr. Massie's comments on this earlier in this hearing. I just want you from the perspective of a small inventor to tell us what you have heard about the difficulty of defending their patent in different venues or having multiple parties come after them? Mr. Squires. Thank you for the question. Before I took office, I represented startups, small entities, and small inventors for about 10 years. I may be the only director who has had that direct experience. It has been a terrible problem, as you have referenced. Sometimes we have seen as many as seven petitions keep coming in waves. That is why under the NPRM we are saying that we have to have some parity, quiet title finally. If you want to still have multiple filings or multiple parties, join it. One join and done. To your question on the individual small entities' experience, it is a killer. People are not able to become I am aware of a funny little patent emanating out of Stanford in 1999, the PageRank patent. That is now, of course, Google. Where our next Googles are coming from, where our next big companies and big tech are coming from start in someone's garage, and they are small inventors and they need to have the same respect as afforded everybody in the system. Ms. Ross. Great. Well, I am a cosponsor of the bipartisan, bicameral PREVAIL Act along with Congressman Moran from Texas, and then, of course, Senator Tillis and Senator Coons. We are hoping that bill will get a hearing. Then Congress can have its say. I do want to ask a question that was mentioned in some of the opening statements. As we know, there have been reports that the USPTO and the Department of Commerce are considering plans to institute a value-based patent fee. Last fall I led a bipartisan effort with several Members of this Subcommittee to Secretary Lutnick urging the Department not to move ahead with the patent tax because, again, I believe it will hurt small inventors more. Although Secretary Lutnick recently said in a Senate hearing that this was not a plan, his answer appeared to leave open the possibility of extracting more value from patents by other means. At any point in your tenure at Commerce or with PTO have you considered this value-based patent tax? How would you implement it if you did it? Mr. Squires. Thank you for the question. I echo Secretary Lutnick's statements. He explained how you would do that, how you would value that. I have never been in those discussions where value had any consideration. It is not something that is on the table or even could be done. Certainly, the Patent Office would not be in the business of providing market valuations for people on their patents. We are in the business of granting them, making sure they are Born Strong, and letting the market work. Ms. Ross. Well, thank you. I hope it remains that way. I yield back. Mr. Issa. I thank the gentlelady. I now recognize the gentlelady from Florida for five minutes. Mr. Massie. I have an unanimous consent. Mr. Issa. The gentleman is recognized for a unanimous consent. Mr. Massie. I ask unanimous consent to submit a five-page letter from a U.S. inventor to the record. Mr. Issa. Without objection, so ordered. Mr. Massie. Thank you. Mr. Issa. Now, the gentlelady may proceed. Ms. Lee. Thank you, Mr. Chair. Director Squires, thank you for being here with us today. The work of the U.S. Patent and Trademark Office plays such a critical role in supporting innovation, protecting intellectual property, and ensuring our patent system functions effectively for businesses and inventors. I appreciate your time with us here today. I continue to hear from retailers and manufacturers, and Main Street businesses that they are being sued for widely used off-the-shelf technology like Wi-Fi systems or point of sale devices, and being forced into settlements because the expense associated with litigating in our Article III courts is simply too high. How do you respond to concerns that limiting access to PTAB is increasing litigation costs and forcing small businesses into these settlements? Mr. Squires. Thank you for the question. The high cost of litigation is, of course, a concern. That is why under the AIA IPRs were designed as an alternative to litigation, lower cost litigation. The IPR is not the only game in town. People also tend to conflate PTAB, limiting PTAB. That is not what is intending to happen, that is not what we were intending with the rule. There is always the avenue of reexamination. We would love to see people utilize PGRs more effectively, sooner in time, clearer title. In general, we preferred a more laid open model where you take your shot but take it now and take it once and for all. As I said, instead of one and done, people need to think about as one join and done. There is the ability for collective action and there is also, then, of course, District Court. There is at least three alternatives available under the PTAB. Ms. Lee. One of the other things I think is important on that front in trying to minimize that down the road litigation you touched on in your opening testimony. That really is the quality of the initial examination. I want to hear more about what you are doing with artificial intelligence and how AI is being used on the initial patent examination. Particularly I would like to hear you have emphasized human-in-the-loop approach using AI but also having humans involved. Tell us a little bit more about that and what safeguards do you have in place to ensure that using AI tools is not introducing any sort of bias or narrowing the scope of prior art consideration? Mr. Squires. Thank you for the question. It has multiple touch points, of course, in the office. I will give you one example. We have launched what we call ASAP!, an AI-generated pilot program which takes the prior art, gets it to the applicant before the first office action. Literally, the examiners and the applicant are on the same page as the prior art beforehand. They have some agency as to what they want to do. They can make an amendment. They can marshal their arguments or decide this is not going to go well, we are not going to waste our resources, and refile with something direct to their resources to something that might be more productive. We are trying to get information in the hands of people at soon as possible point where they can do something with it and have people be on the same page. On the eligibility side we have formed a 101-working group. We had started to deploy AI agents to assist in some of the areas where there are the thornier issues to decide on 101 and to give some assistance to the examiners. Always it will be a human in the loop. The larger vision is, as I mentioned in my opening statement, to have the examiners be able to examine a cadre of agents, deploy them as they see fit to their cases, and be able to do thousands of hours in hundreds of hours' time but still remain expert in their field, and be just as equipped as the private sector applications coming in to meet the examination challenge. Ms. Lee. Thank you, Director. I yield the balance of my time to the Chair. Mr. Issa. I thank the gentlelady. A couple of quick things. You keep talking about these off-ramps, these other opportunities. Just between two people who have dealt with patents for a long time, an ex parte reexamination is exactly that, it is the inventor and an examiner, sometimes the same examiner, sometimes someone different, talking about whether or not some third-party allegation is correct or not. It is a one-sided process that favors dramatically the same or substantially same patent. It is not an even playing field. The PTAB exists because ex parte was ending almost always successfully favoring the reinstatement or the continuation of a patent compared to the outcome of PTAB. Isn't that true? It is not a place that really if you have been accused it makes any sense to throw it and hope for the best without seeing anything until it comes out? Mr. Squires. That may have been the case in the past with reexamination. I don't believe it is that case now. In fact, it has become a quicker and almost the same outcome experience as the PTAB has been. Mr. Issa. I appreciate that. I would love to have a longer dialog, but I don't own the time. The gentlelady from California is recognized for five minutes. Ms. Kamlager-Dove. Thank you, Mr. Chair. Director Squires, before we get into your recent policies, I just want to make sure that we are grounded in the basics because much of this debate seems to move past them too quickly. To my understanding IPR is an administrative process allowing parties to ask the Patent Trial and Appeal Board to reexamine whether an already-issued patent is valid. It was created to provide a faster, more cost-effective alternative to litigating patent validity in Federal court, recognizing that initial patent review can be imperfect. Instituting a review means the board agrees there is enough merit to examine the challenge, while denying institution means the challenge does not move forward. Is that correct? Mr. Squires. In general, the IPR process has two components, one discretionary and one merits. Ms. Kamlager-Dove. Right. OK. At the end of the day, it is ultimately about protecting U.S. companies, inventors in those parents? That is what we are here to. Mr. Squires. We are trying to make sure where there has been, especially when there has been error in examination-- Ms. Kamlager-Dove. Right. Mr. Squires. --there is redress available. Ms. Kamlager-Dove. OK. There are concerns raised that IPR may disproportionately impact individual inventors and small entities. There has been discussion about nonpracticing entities, entities that assert patents but do not manufacture a product, and their role in patent litigation, including some that may have foreign ownership or backing. Does the USPTO distinguish between different types of patent holders when evaluating how PTAB policies affect stakeholders? Mr. Squires. It is certainly a discretionary consideration that we invite people to tell their story. As I said, we just recently announced guidance that for American manufacturers, or if they are patent holders and there are petitions filed against us, tell us about that. We want to know. Conversely, if they are State actors or foreign sovereigns they can't be in PTAB under the recent return mail application to foreign sovereigns or State actors. We need to know who is there and what their particular situation is. Also, with the guidance on the manufacturing we reference small businesses. We want to know what the dynamic of whatever side you are on is before instituting proceedings. Ms. Kamlager-Dove. OK. You are saying if there are sovereigns, if there are foreign actors, you do want to know? Mr. Squires. Well, we need to know because they aren't allowed any feedback. Ms. Kamlager-Dove. Yes. OK. That means that you also have collected this data. You have done data collection on this so you know? Mr. Squires. There is a real party-in-interest requirement. Ms. Kamlager-Dove. Uh-huh. Mr. Squires. The RPIs have to be identified at the time of filing. That is a disclosure. It can be raised by the patent holder in response to a petition, and so it's a disclosure type process. We do have data on the number of foreign State actors who collectively from foreign countries who have appeared in PTAB historically. If you aggregate them, they would rank No. 4. Ms. Kamlager-Dove. OK. If I asked you to provide to this Committee a breakdown of that data, so, broken down by entity type, domestic versus foreign ownership, whether the patent holder manufactures anything, you would be able to do that? Mr. Squires. I don't know the extent to what granularity we have. Ms. Kamlager-Dove. Uh-huh. Mr. Squires. I can provide you with a list of who the filers are, yes. Ms. Kamlager-Dove. All right. Well, that would be helpful because I think the question is, are different entities treated differently? Small versus big is always going to be an issue. When there is also concern that a company has foreign backing, for me that also raises national security concerns; right? I wouldn't want a Huawei, for example, getting in the mix and playing a role in seeking or holding a patent that should be for a U.S. inventor or company. Mr. Squires. I understand. We are happy to work with your office. I would direct your attention to the Corning Optical memo that I issued, which did have a listing of IPR petitioners in aggregate by IPR petition. Ms. Kamlager-Dove. OK, great. We are on the record as saying we are requesting that information. We would love it for you to be able to share that with the Committee. Mr. Squires. Thank you. Ms. Kamlager-Dove. I do have--I am sorry. Mr. Issa. Do you have an unanimous consent? Ms. Kamlager-Dove. Yes, I do, Chair. Ask unanimous consent to enter into the record, ``Trump appointees are hijacking the patent system.'' This is dated May 2025 prospect. The next one, enter into the record ``Trump's PTO Pick's Fortress Ties Signal Base Tech Patent Fights.'' Mr. Issa. So ordered. Ms. Kamlager-Dove. Without objection. Thank you. Mr. Issa. At this time, I will also put into the record by unanimous consent a copy of the docket for the Patent and Trademark Office, the revised proposed rules that we have been alluding to. Additionally, a number of letters. I will ask them to be placed en bloc which they do include, but not limited to, patents for affordable drugs, general action patent, Crypto Counsel on Innovation, and a number of others. Without objection, so ordered. We now go to the gentleman from South Carolina for his five minutes. Mr. Johnson. Mr. Chair, I have a unanimous consent. I would like to enter into the record a letter from the Counsel for Innovation Promotion, dated March 24, 2026, addressed to yourself and me regarding this hearing. Mr. Issa. Without objection, so ordered. The very patient gentleman from South Carolina is recognized. Mr. Fry. Thank you, Mr. Chair. Director, thank you for being here. The PPAC and TTAC have served as effective vehicles for the private sector subject matter experts to offer specialized guidance to the PTO. I would like to commend you and Secretary Lutnick for appointing new members to these bodies last fall. When do you anticipate the remaining vacancies to be filled and the Committees will reconstitute and begin their work? Mr. Squires. Thank you for the question. Very soon. As we have seen both on the PPAC and TTAC side there is really an all-star roster. We just extended an offer last night to the individual mentor which is the statutorily required person that crystalized everything. We are hopeful very soon. Mr. Fry. Great. Thank you for that. I am going to move on to a separate issue on U.S. research and development. Obviously, we are competing with China on any number of things across many fields: Medicine, telecommunications, manufacturing, and emerging technologies. In the context of patents, how do China and foreign competitors undermine our system in your view, very briefly? Mr. Squires. As brief as I can. In several ways. One is known as flooding the zone. We have seen a lot of low-quality applications in different areas. Others are fraudulent filings which we have deployed some AI tools and identified. As I said, we have moved, especially on the trademark register, and tens of thousands of fraudulent applications. The third arrow in our quiver that we just announced is a rule that you must be a U.S. practitioner before the Patent Office and to file papers. Accountability is, of course, important. Those are ways we are trying to address these issues. Mr. Fry. Regarding pharmaceuticals, what steps has your office taken or plans to take to ensure that the U.S. remains a global leader in pharmaceutical innovation? Mr. Squires. Again, our No. 1 goal is to have patents Born Strong, make sure they receive rigorous and thorough examination, and get to market in a timely manner. Mr. Fry. Switching gears again, on the IPR, we have talked about that a lot today, how is the office thinking about striking the right balance related to IPR, ensuring that manufacturers and strategic industries can effectively defend against questionable patents while also preserving the strong protections in access for small businesses, startups, and independent ventures? Mr. Squires. Thank you for the question. Yes, it is, balance is the key word. It is a unitary system. I like to quip sometimes that means that someone is always unhappy. Nevertheless, we are trying to strike the balance, especially on the discretionary side, as I mentioned, where there are small business factors or manufacturing, it cuts both ways. Tell us your story. We even had issues where things that have been controversial, like I said, all expectations cut both ways. There have been assertions where patents have lapsed and then come into being, or licenses have been issued against the expectations, and those get taken into account whether to institute or not. Mr. Fry. Thank you for that. You would agree that China-- you said flood the zone earlier--so you would agree with me that nation-states like China challenge current patents or trademarks pretty frequently. Is that fair to say? Mr. Squires. They have. The new precedent will end that process. Mr. Fry. OK. How do we deal with domestic companies that do that? I will give you an example. The Monster Energy drink is like the No. 1 filer against existing trademark applications. They are far and away above everybody else. They have been labeled as a trademark bully of the year by multiple times, at least since 2012. I don't want to single them out, but I do think it is real problematic. Some of these cases are like camping gear because the name is 4Monster; a craft brewery company. What I am concerned about is big companies with a lot of assets that come in and swing at small restaurant owners. I guess there was a restaurant in Ohio, it is a shawarma restaurant and they are called the Monster Shawarma. Somehow that is a patent or a trademark infringement on Monster. It is just really aggressive. How do we protect small businesses against trolls like Monster Energy drinks? Mr. Squires. It is a difficult question. The way we protect them is, I early access files if they can. Monster, of course, has a famous mark and it has a wider berth in courts in assertion. A trademark system is a registration system. It levers off of use in commerce, often from State rights. They register Federal as that. The part of the solution is to let people know we are here. You should file. Mr. Fry. What about Rule 11 sanctions? If they are filing frivolous things and they are, obviously, I am not suggesting that all their cases are not meritorious, but I am suggesting that it is a little bit alarming that they are the No. 1 company in the country filing against small businesses. They are really aggressive in their tactics. What I would like to know is if you have got tools in your toolbelt to rein some of these practices in. You have already got a full docket. How do we rein in companies like that from abusing the system? Mr. Squires. Again, thank you for the question. On the Rule 11 basis that is, of course, more of a District Court litigation dynamic. In terms of utilizing our office in terms of oppositions per se, those are something that we do have a TTAB and we do have discretion around those types of matters. Again, just like the patent side, tell us your story. That is often compelling. We are trying to be responsive to the real-world dynamics out there. Mr. Fry. I appreciate you doing that. This isn't a criticism of you or the office. I just want to make sure. Obviously, we want to focus on China and the things that they are doing to undermine our competitiveness. We also have some problems domestically, too, some of these people that abuse the system. Thank you, Mr. Chair. Mr. Issa. That is great. Just one clarification. You used the term famous mark. IBM is a famous mark. Ford Motor is a famous mark. Monster Cable doesn't--Monster drinks don't meet that requirement, does it? You used it but I don't think you meant to use it. Mr. Squires. I have not come to that conclusion, but-- Mr. Issa. To be a famous mark, the word monster all by itself would have a secondary meaning; right? Mr. Squires. That would be for a court to decide. Those are the parameters, yes. Mr. Issa. OK. Monster movie, Monster Cable, which every, every professional musician uses and predates Monster drinks, I am trying to understand because it is important for this hearing. Do you want to go back and revise for the record your statement that Monster drinks is somehow because it, obviously, is a huge difference in how you and the courts deal with that allegation; right? Mr. Squires. I would revise my saying and say if Monster is famous mark then these the types of things that they could do in court. Mr. Issa. I absolutely agree with you. I have certainly seen a blue oval without the word Ford be considered as important because it is a famous mark. I appreciate that. I now ask unanimous consent en bloc that a number including submissions includes from Arnold Ventures, from Entertainment Software Association, from the ES--that is the same one. Hang on for one second. Yes, OK, from the Business Software Alliance. Some of these are long. They really have things to say to you, Mr. Secretary. From the most famous of all, the CTA, the Consumer Technology Association, who opined in the negative, to say the least. There are too numerous. We will be giving them all to you. Without objection, so ordered. I now recognize myself for a number of questions. Isn't it true that the number of so-called serial applications, the repeat use of PTAB, was less than one percent? Yet, your rule applies to 100 percent. Is that correct? The historical serial attacks using PTAB is less than one percent? Mr. Squires. Of PTAB actions filed, of IPR actions filed? Mr. Issa. Correct, sir. Mr. Squires. I don't know the exact figure. I will-- Mr. Issa. OK. That is the figure that staff on this side comes up with. Please give us your answer for the record. I have already discussed the ex parte. We are going to agree to disagree that you performed anything, simply because it is still a process that there are only two people in the room and one of them is not the person who submitted the documentation, they are not part of the process. That is why it is ex parte; correct? Mr. Squires. That is correct, ex parte. Mr. Issa. OK. I have got a great many items to say the least, as you could tell. Probably the largest one is currently when I mentioned that you have taken cases in which they were discretionarily allowed. Process had nearly reached a conclusion and then you pulled them back, essentially retroactively, discretionarily said they never existed. Where do you believe you get that authority? Mr. Squires. I don't know which specific cases you are referring to or the particular facts of the matter, but the Federal Circuit has-- Mr. Issa. It would be that Interactive Communications is one example that we have that you did that to. I cite this because when it goes to a final decision, if you want to reverse it you can, but there has to be, essentially, it is not without paper. When you simply do a denial there is no paper, as we have seen today. Retroactively doing it makes a huge different because that discretionary denial after the facts have been laid out, after it has gone through the process and expense then denies the individuals either an outcome, possibly reversible, or an explanation, which you did not give in that case. Mr. Squires. Again, I am not familiar with the underlying case even by caption. However, there is wide discretion afforded. I believe the use of discretion would include changing your mind. Mr. Issa. Well, I don't believe you have that discretion once a process begins. We would like you to cite, as you did very eloquently in others, where you believe in the America Invents Act that you believe you have that discretion. Because we disagree. Additionally, since that discretion is not challengeable in court and, yet, the final decision would be, you see where the ambiguity is. You have taken away the ability to have additional appeal because you have denied them by using the discretionary denial after the fact, which takes away their ability to actually have any further redress. Correct? Mr. Squires. I don't agree with that. The authority is 316- 35 U.S.C. 316(b). I am required by statute in rulemaking, we use this in our decisions for to take into account the economy, integrity of the patent system, and the efficient use of resources in the discretionary part of our what we do. The merits part is different, of course. The discretion piece is the one component before you get to the merits. Mr. Issa. OK. I am going to use my final time to ask some very tough questions. You mentioned Secretary Lutnick having 500 patents. Is it true that, to your knowledge, that the Secretary during his tenure was often a plaintiff suing in District Court, directly or indirectly? Mr. Squires. I am recalling days of eSpeed and BrokerTec, and there were several suits back in the 2000s around that. Mr. Issa. It is fair to say that from the monetary standpoint he benefited from lawsuits and may or may not have an opinion on whether he likes PTAB or not, since he began reducing PTAB's effectiveness during his tenure before you came onboard directing the acting? Have you had any discussions with the Secretary concerning any of these policies? Mr. Squires. The NPRM that was issued is the Secretary's first and signature rule. He was absolutely behind those. Mr. Issa. OK. As you sit here today the Secretary has a role. Let me ask one last question. To your knowledge has the Secretary eliminated all owned assets that could in any way benefit from these changes? Mr. Squires. I have no knowledge one way or the other. Mr. Issa. OK. Would you to the best of your ability ask for the record, or perhaps we will ask the Secretary directly by subpoena. It is my understanding that he may not have eliminated all his holdings. Therefore, there could genuinely be a conflict as you, whether right or wrong, whether you have authority or not, dismantle PTAB cutting by 80 judges and continuing to cut by discretionary, both regular and retroactive. There is a lot more to ask. I will ask the rest of them for the record and ask that you agree to answer them if we send them to you within five days? That is actually a question we normally ask at the end by unanimous consent. If you will agree to take written questions from the record from all Members? Mr. Squires. I would welcome the chance to interact with this body. Mr. Issa. Thank you. In conclusion, this has been an illustrative hearing. I will say, and this is usually something the Minority would be saying, that it has been too long, it took too long. We are now over 15 months into an Administration, and this is the first visit of a Committee that to the Committee of jurisdiction. It is our hope that prior to the close of this Congress that we will have you back for at least one additional hearing, not to repeat the subjects but to followup on them. It is the normal practice to have a regular dialog with the Patent and Trademark Office. It is my personal hope, and I believe the Ranking Member's personal hope, that this dialog will continue so that by the time we come to the next one we won't be talking in single digits how often we have been able to have interactions with your office directly. With that, I am required to say this concludes today's hearing. I want to thank our witness for appearing before the Congress. Without objection, all Members will have five legislative days to submit additional written questions, and to the witness, and additional materials for the record. Without objection, we stand adjourned. [Whereupon, at 12:08 p.m., the Subcommittee was adjourned.] All materials submitted for the record by Members of the Subcommittee on Courts, Intellectual Property, and the Internet can be found at: https://docs.house.gov/Committee/Calendar/ByEvent .aspx?EventID=119088. [all]